Skip to content

Report: Analyzing the Procurement of TB Drugs in 4 EECA Countries

30 June 2025

The TB Europe Coalition released a report summarizing the findings of a 2024 community-led monitoring (CLM) initiative that assessed the procurement processes for shorter TB treatment regimens in four Eastern Europe and Central Asia (EECA) countries over the 2022–2024 period.

As a mechanism ensuring independent oversight and community engagement, the CLM focused on evaluating the current status of access to and availability of the latest shorter TB treatment regimens, as well as identifying existing gaps in Kyrgyzstan, Moldova, Tajikistan, and Ukraine.

The assessment covered national legislation and international procurement mechanisms and projects related to TB drugs for shorter treatment regimens. This included funding and procurement volumes, international nonproprietary names, quantities, prices, and manufacturers. Interviews were also conducted with specialists from the national TB programs’ pharmaceutical and statistical units.

Access the report here.

 

Source: TB Europe Coalition

Back To Top